148 related articles for article (PubMed ID: 34489390)
41. [Extended-field intensity modulated radiation therapy and intra-cavitary brachytherapy combined with chemotherapy for stage Ib1-IVa cervical cancer with positive para-aortic lymph nodes].
Ke GH; Huang X; Huang XW; Liu SP; Wu XH
Zhonghua Fu Chan Ke Za Zhi; 2013 Sep; 48(9):649-53. PubMed ID: 24332129
[TBL] [Abstract][Full Text] [Related]
42. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
Niibe Y; Tsunoda S; Jobo T; Imai M; Matsuo K; Matsunaga K; Unno N; Hayakawa K
Eur J Gynaecol Oncol; 2008; 29(3):222-4. PubMed ID: 18592783
[TBL] [Abstract][Full Text] [Related]
43. Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.
Mell LK; Xu R; Yashar CM; McHale MT; Einck JP; Mayadev J; Lee E; Binder P; Rash D; Eskander R; Heide ES; Plaxe SC; Mundt AJ; Saenz CC
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):964-973. PubMed ID: 32334034
[TBL] [Abstract][Full Text] [Related]
44. A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.
Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Ito K; Tsutui T; Ogata T; Yoshioka Y; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Sep; 23(7):1279-86. PubMed ID: 23835505
[TBL] [Abstract][Full Text] [Related]
45. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
[TBL] [Abstract][Full Text] [Related]
46. Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma - a Role in Patients with Para-aortic Lymph Node Involvement? A 10-year Institutional Experience.
Green HM; Counsell N; Ward A; McCormack M
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):e281-e290. PubMed ID: 35000828
[TBL] [Abstract][Full Text] [Related]
47. Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
Lee J; Lin JB; Chang CL; Jan YT; Sun FJ; Wu MH; Chen YJ
Gynecol Oncol; 2017 Jul; 146(1):20-26. PubMed ID: 28457584
[TBL] [Abstract][Full Text] [Related]
48. Sentinel lymph node procedure followed by laparoscopic pelvic and paraaortic lymphadenectomy in women with IB2-II cervical cancer.
Lavoué V; Bats AS; Rouzier R; Coutant C; Barranger E; Daraï E
Ann Surg Oncol; 2007 Sep; 14(9):2654-61. PubMed ID: 17610015
[TBL] [Abstract][Full Text] [Related]
49. Prophylactic Extended-Field Irradiation for Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy: A Propensity-Score Matching Analysis.
Wang W; Liu X; Meng Q; Zhang F; Hu K
Int J Gynecol Cancer; 2018 Oct; 28(8):1584-1591. PubMed ID: 30153215
[TBL] [Abstract][Full Text] [Related]
50. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
51. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer.
Rash DL; Lee YC; Kashefi A; Durbin-Johnson B; Mathai M; Valicenti R; Mayadev JS
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):317-22. PubMed ID: 23906933
[TBL] [Abstract][Full Text] [Related]
52. Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study.
Du XL; Sheng XG; Jiang T; Yu H; Yan YF; Gao R; Lu CH; Li QS
Croat Med J; 2010 Jun; 51(3):229-36. PubMed ID: 20564766
[TBL] [Abstract][Full Text] [Related]
53. IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Cihoric N; Tapia C; Krüger K; Aebersold DM; Klaeser B; Lössl K
Radiat Oncol; 2014 Mar; 9():83. PubMed ID: 24661323
[TBL] [Abstract][Full Text] [Related]
54. Optimal Extent of Prophylactic Irradiation of Paraaortic Lymph Nodes in Patients with Uterine Cervical Cancer.
Choi J; Yoon HI; Lee J; Keum KC; Kim GE; Kim YB
PLoS One; 2015; 10(12):e0145158. PubMed ID: 26659867
[TBL] [Abstract][Full Text] [Related]
55. RapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: a treatment planning comparison with fixed field IMRT.
Zhai DY; Yin Y; Gong GZ; Liu TH; Chen JH; Ma CS; Lu J
J Radiat Res; 2013 Jan; 54(1):166-73. PubMed ID: 23283869
[TBL] [Abstract][Full Text] [Related]
56. Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases: a retrospective review in a single institution.
Zhang G; Fu C; Zhang Y; Wang J; Qiao N; Yang Q; Cheng Y
Int J Gynecol Cancer; 2012 Sep; 22(7):1220-5. PubMed ID: 22854654
[TBL] [Abstract][Full Text] [Related]
57. The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.
Yap ML; Cuartero J; Yan J; Pintilie M; Fyles A; Levin W; Manchul L; Milosevic M
Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):797-803. PubMed ID: 25194726
[TBL] [Abstract][Full Text] [Related]
58. Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
Jiang Y; Wang J; Jiang P; Wang X; Zhang L; Zhang Y
BMC Cancer; 2023 May; 23(1):481. PubMed ID: 37245053
[TBL] [Abstract][Full Text] [Related]
59. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
[TBL] [Abstract][Full Text] [Related]
60. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
